Showing 1 - 2 results of 2 for search 'Natasha de Peyrecave', query time: 0.01s Refine Results
  1. 1
    Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis

    Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial... by Filip van den Bosch, Martin Rudwaleit, Helena Marzo-Ortega, Natasha de Peyrecave, Victoria Navarro-Compán, Lars Bauer, Rachel Tham, Thomas Kumke, Mindy Kim

    Published 2024-08-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging

    Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomise... by Xenofon Baraliakos, Jerney de Jongh, Denis Poddubnyy, Gerben J. C. Zwezerijnen, Robert Hemke, Sophie Glatt, Stevan Shaw, Lucian Ionescu, Assem el Baghdady, Joanne Mann, Ralph Paul Maguire, Tom Vaux, Natasha de Peyrecave, Marga Oortgiesen, Dominique Baeten, Conny van der Laken

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: